Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS)
Chaurasia, P, Isoda, F, Navada, S, Odchimar-Reissig, R, Demakos, E.P, Reddy, E.P, Silverman, L.R
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
239 PATTERNS OF CARE FOR HYPOMETHYLATING AGENTS (HMAS) IN MDS PATIENTS IN THE US: A DISTURBING LACK OF OPTIMAL TREATMENT TRANSLATES TO A RECIPE FOR FAILURE
Demakos, E.P, Silverman, L.R, Lawrence, M.E, McKearn, T.J, Megaffin, S, Petrone, M.E
Published in Leukemia research (01.04.2015)
Published in Leukemia research (01.04.2015)
Get full text
Journal Article
P-274 Rigosertib activity in patients with a myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) relapsed or refractory to hypomethylating agents
Navada, S.C, Odchimar-Reissig, R, Reddy, E.P, Demakos, E.P, Holland, J.F, Wilhelm, F, Silverman, L.R
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
204 - Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS)
Chaurasia, P., Isoda, F., Navada, S., Odchimar-Reissig, R., Demakos, E.P., Reddy, E.P., Silverman, L.R.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis
Rondelli, D, Goldberg, J.D, Marchioli, R, Isola, L, Shore, T.B, Prchal, J.T, Bacigalupo, A, Rambaldi, A, Klisovic, R.B, Gupta, V, Andreasson, B, Demakos, E.P, Price, L.S, Scarano, M, Wetzler, M, Vannucchi, A.M, Najfeld, V, Barosi, G, Silverman, L.R, Hoffman, R
Published in Biology of blood and marrow transplantation (2012)
Published in Biology of blood and marrow transplantation (2012)
Get full text
Journal Article
PS1332 RIGOSERTIB MODULATES HEMATOPOIESIS GENE SIGNALING PATHWAYS ALONE OR IN SEQUENCED COMBINATION WITH AZACTIDINE ON MDS CELLS IN VITRO
Rai, R., Melana, S., Navada, S.C., Odchimar‐Reissig, R., Demakos, E.P., Reddy, E.P., Silverman, L.R.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
S839 PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (MDS)
Navada, S.C., Garcia‐Manero, G., Atallah, E., Rajeh, M.N., Shammo, J.M., Griffiths, E.A., Khaled, S.K., Dakhil, S.R., Young, D.E., Odchimar‐Reissig, R., Demakos, E.P., Alvarado Valero, Y., Ohanian, M.N., Pemmaraju, N., John, R.B., Zbyszewski, P.S., Maniar, M., Petrone, M.E., Woodman, R.C., Fruchtman, S.M., Silverman, L.R.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article